Cyberattack Paralyzes the Largest U.S. Health Care Payment System
Newswire
Pharma has little visibility into the growing area of PBM fees
The antitrust tripwire for health insurers Cigna and Humana
How Cigna saves millions by having its doctors reject claims without reading them
How the secrecy of middlemen inflates drug prices
Ending Junk Fees, the Most Annoying Thing in American Commerce
Drug Benefit Firms Devise New Fees That Go to Them, Not Clients
Kickbacks Are The Root Cause Of Medical Supply Shortages
Congress Voices Bipartisan Support for FTC’s Fight Against Monopoly Power
How UHC’s acquisition of a popular Medicare Adv. algorithm sparked internal dissent over denied care
‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
State Insurance Commissioners Seek Meeting With FTC On PBMs
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
FTC Deepens Inquiry into Prescription Drug Middlemen
Cigna hit with ERISA class action lawsuit for allegedly overcharging members
Did Lina Khan Just Slash Insulin Prices?
Middlemen Running Amok
How the FTC's crackdown on GoodRx could impact digital health
With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
$189 charged, $15 collected: The life and death of a local independent drugstore
We Need Your Support Today!